Introduction
T he viral hemorrhagic fever viruses are arthropod-bome or rodent-bome viral infections that can result in hemorrhage and shock. In the case of the filovlruses, the transmission to humans and the natural reservoir are not known. The viral hemorrhagic fever viruses can produce a clinical syndrome that is characterized by fever, severe systemic symptoms such as headache, myalgias, arthralgias, nausea, vomiting, and diarrhea, and varying degrees of eoagulopathy. Coagulopathy is a distinguishing feature of the viral hemorrhagic fever viruses and is manifested by hemorrhage into the skin as petechiae or ecchymoses, oozing at puncture sites, epistaxis, gingival bleeding, hematemesis, melena, and severe vaginal bleeding. Cardiovascular collapse and shock syndrome can occur through blood loss or intravascular plasma leakage into the extravascular space.
The viral hemorrhagic fever viruses are represented by a variety of RNA viruses with varying vectors of transmission, epidemiology, pathogenesis, and case fatality rates. The RNA viruses are highly susceptible to point mutations, in the range of 10 '' to 10 ^ substitutions per nucleotide copied, and undergo homologous and heterologous recombination, gene reassortments, and formation of quasispecies during replication.''^ The high mutation and recombination rates observed explain in part the great deal of genetic diversity seen among the RNA viruses.T he result is a virus that undergoes rapid evolution and that can become highly adaptable to the host and the environment. The diversity of the viral hemorrhagic fever viruses and their adaptability to the host and the environment result in a group of pathogens that have been in the past, are currently, and potentially will be in the future major disease threats to military personnel deployed in vims-endemic areas. This article is a review of the military significance of the viral hemorrhagic fever viruses and the contributions of military scientists toward understanding the viruses.
Dengue
Dengue is an expanding public health problem in the tropics and subtropics. Reports suggest that 2.5 billion people are at risk for dengue, with up to 100 million dengue virus infections occurring each year and more than 60,000 reported deaths.''"'' Dengue transmission occurs in Central and South America, South and Southeast Asia, Africa, and the Caribbean and Pacific regions. There have been recent outbreaks in Texas, Florida, and Hawaii.''"^ Population growth, urbanization, and regional and international travel sustain the continually worsening global dengue situation.'°"
The U.S. military has made great contributions to the understanding of the etiology, epidemiology, immunology, and pathogenesis of dengue vims infections. Numerous dengue vaccine candidates have been developed by the U.S. military and are being evaluated in Phase I/II clinical trials.
Dengue vimses belong to the genus Ravivims and the family Flaviviridae.'^ The virion is a single-strand, positive-sense, RNA genome coding for capsid, membrane, and envelope proteins and seven nonstmctural proteins (NSl, NS2a, NS2b, NS3, NS4a, NS4b, and NS5). ' The dengue vimses exhibit substantial genetic diversity, exemplified by the existence of four distinct serotypes (DEN-1-4). '^'^ The genetic diversity and phylogenetic relationships of dengue vims strains isolated from different parts of the world suggest the existence of numerous DEN-1, -2, -3, and -4 genotypes."^^T he pathogenesis and pathophysiology of severe dengue vims infections (dengue hemorrhagic fever) remain incompletely understood. Early theories were based on clinical observations and seroepidemiological studies.^^"^^ An extensive body of work describing clinical and basic science observations on pathogenesis has been completed by U.S. military scientists and their collaborators at the Walter Reed Army Institute of Research (WRAIR)
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(Silver Spring, Maryland) and the Armed Forces Research Institute of Medical Sciences (Bangkok, Thailand).^''"^M ost dengue hemorrhagic fever cases occur among persons sustaining secondary dengue virus infections with heterologous dengue vims serotypes.^^ The immune-enhancement theory of dengue pathogenesis states that cross-reactive non-neutralizing antibodies from a previous heterologous dengue virus infection facilitate dengue vims entry into Fc receptor-bearing cells such as monocytes and maerophages. This increase in the number of infected cells leads to more severe disease.^^ The sequence of infecting dengue vims serotypes,^^^^ genetic diversity among genotypes, race, gender, age, and preexisting chronic diseases may all affect the clinical severity of infection.*""^Û The U.S. military is also involved in the development and testing of several second-generation dengue vaccines. Inactivated whole-vims and reeombinant subunit vaeeines are being pursued.^^'^° DNA vaeeines show promise as a stand-alone approach or as a "prtme-boost" with inactivated vaceines.^'"^'' The U.S. Naval Medieal Research Center has conducted work on improving DNA vaecine immunogenicity by using novel methods of vaccine delivery and adjuvants to stimulate the immune response.^''^^'^^ An inactivated, monovalent, dengue vaecine eandidate has been tested in nonhuman prtmates and is ready for Phase I elinical testing in humans.^^'^^'
The laek of an approprtate animal model for dengue infection and vaeeine immunogetiieity has delayed the development and testing of candidate vaccines. Recent U.S. Army attempts to reintroduce a human challenge model ofier an approach to evaluating the efficacy of modem vaccines before field efiicaey testing with large numbers of suseeptible volunteers.'^^'^^ Experimental infection of human volunteers with dengue vims has been produced aniiong many hundreds of volunteers since the beginning of the last century, without untoward efFects.' *™'' '^-^' ' -^^-'Ŷ
ellow Fever
Since the 17th century, YF epidemics have strained public health and economic systems in the Amertcas, Europe, and Afrtea.'"^ Today, YF continues to affect communities in tropical South Amertca and sub-Saharan Afrtea. There are estimates of 200,000 cases oceurrtng annually, with a case fatality rate of 20 to 50%.'°^ YF vims has the distinction of being the first vims to be demonstrated as a cause of human disease transmitted by an arthropod, the A. aegypti mosquito. Griffin Hughes is given credit for being the first to use the term "yellow fever" in his book "Natural History of Barbados" (1750 
U.S. Military Contributions

The Yellow Fever Commission
Early efforts of the eommission focused on validation of the 1897 theory of Italian baetertologist Giuseppe Sanarelli that Bacillus icteroides caused YF. This work was conducted much to the dismay of Lazear, who wrote to his wife on August 23, 1900, "... I would rather try to find the germ without bothertng with Sanarelli.""^ The dismissal of B. icteroides as a cause of YF diminished support for the fomite theory of transmission (e.g., eontaminated clothing and sheets) and built evidence for the transmission to humans via an intermediate host. This led to testing of the mosquito theory of the Cuban scientist Carlos J. Finlay and the famous human use trtals to diseover the answers desertbed below.'"F rom August 11 to 25, 1900, the equivalent of YF mosquito inoculation challenge expertments were eondueted on nine different oeeasions, all failing to reproduee elinical YF. Lazear challenged Carroll on August 27, 1900, and soldier William J. Dean 4 days later; both quickly developed YF."^ The contrasting circumstance of the latter challenges was that the mosquitoes for Carroll and Dean had fed on YF patients durtng the first 3 days of illness (peak viremia) and were used to challenge after 12 days. The delay in mosquito challenge allowed the required viral "extrinsie ineuhation" period to oeeur. Lazear also developed YF; the eireumstanees of his infeetion are unknown hut almost eertainly represent an experimental infeetion. He died of his YF on September 25, 1900.'"
In November 1900, on the rolling fields of the Finea San Jose, the eommission established Camp Lazear, dedieated to their deeeased eoUeague. The eamp eonsisted of two wood-frame buildings and seven tents to aeeommodate and support the study subjeets. Robert P. Cooke, a U.S. Army Medieal Corps physieian, eondueted three trials using 20 study subjeets to disprove the fomite theory of YF transmission."T he eommission subsequently proeeeded with four series of mosquito experiments. In the first, study subjeets developed YF following mosquito inoeulation ehallenge. In the seeond. Reed used ease-eontrol experiments to demonstrate,"... the essential faetor in the infeetion of a building with yellow fever is the presenee therein of mosquitoes, and nothing more.""^The third series of experiments used sueeessive inoeulations by the same mosquitoes, over time, to pinpoint the "extrinsie ineubation" period, the time required for a newly infeeted mosquito to beeome a eompetent veetor of YF, whieh was no less than 11 days. These findings eomplemented the epidemiologieal observations of Henry Rose Carter of the Marine Hospital Serviee, who noted a lag time of 2 to 3 weeks between the identifieation of a YF index ease and subsequent seeondary eases. '°^ The fourth experiment complemented the third by approximately defining the period over whieh YF-infeeted mosquitoes retained their veetor eompeteney, i.e., more than 40 days."T he final experiments involved subeutaneous inoeulations of blood taken from YF-infeeted patients into YF-naive study subjeets. YF was produeed in four study subjeets; subsequent blood eultures from the study subjeets failed to grow B. icteroides, finally laying Sanarelli's theory to rest.
In all, 14 nonfatal eases of YF were produeed during the Camp Lazear experiments."^ Reed et al.^*^ published the results of their experiments in the Journal of the Ameriean Medieal Assoeiation. The U.S. Army ordered a skeptieal Maj William C. Gorgas, the Army's sanitarian in Havana, to complete mosquito source reduction. In 90 days, Havana was free of YF.'°Ŷ
F Vaccine
The Rockefeller Foundation laboratories (New York, New York) developed the 17D live, attenuated, YF vaccine in the 1930s.'" "^"'^^ In more than 60 years, approximately 400 million people have safely received the vaecine."' There have been rare (21 cases) but fatal adverse events (eneephalitis) assoeiated with use of the 17D YF vaeeine, primarily among young ehildren.'^"* Viseerotropie infeetion following vaeeination, similar to natural disease, is thought to refleet atypical host responses rather than genomie instability of the vaeeine."' Durable immunity, in the form of protective neutralizing antibodies, is found for 90% of vaccinees within 10 days and for 99% within 30 days after vaccination.''"
Arenaviruses
The arenaviruses eonstitute the family Arenaviridae, small, enveloped, single-strand, RNA viruses with a unique genetie arrangement. The genome is divided into two segments, designated short and long, eaeh eoding for final protein products in an ambisense orientation. Ribosomes contained within virions give the eharaeteristie sandy appearanee of the virus by eleetron microscopy, thus, the origin of the name arena (Latin, sand).'^N ew arenaviruses are being diseovered at a rate of one every 2 to 3 years. The 20 known species of the family belong to a single genus, Arenavirus, but are taxonomieally divided into Old World and New World (Taearibe eomplex) groups.'^^"'^^ All arenaviruses have elose associations with speeifle rodent hosts, and humans ean become infeeted when exposed to these rodents or, more particularly, their exereta.'^°U .S. Military Significanee A minority of arenaviruses cause signifieant human disease, and only a seleet few are of military importanee. Hemorrhagie fever arenavirus infeetions pose a profound threat to troops deployed to disease-endemic areas, or potentially as biologieal weapons; these are Lassa fever and the South American hemorrhagie fevers. Of the latter, Argentine hemorrhagie fever (eaused by Junin vims) and Bolivian hemorrhagic fever (eaused by Maehupo virus) are the most common. Lassa virus infeetion is frequently mild or subclinieal but, of the 5 to 10% of infeeted persons who develop disease serious enough to require hospitalization, 15 to 25% perish. Lassa fever is differentiated from the other arenavirus hemorrhagie fevers by its low ineidenee (17%) of frank hemorrhage or peteehiae and its proclivity for person-to-person spread. The South Ameriean hemorrhagie fevers are more severe, with overall mortality rates of 15 to 30%. Hemorrhagie features are mueh more eommon in severe eases, and neurologieal symptoms are frequently prominent. Death from arenavirus hemorrhagie fever is thought to result from shoek and eireulatory eoUapse, although the precise meehanism of these events is still unelear.'^^'^°The hemorrhagie fever arenaviruses are highly contagious by aerosol and require Biosafety Level 4 eontainment for laboratory work.
U.S. Military Contributions
Military medieal seientists have been at the forefront of researching these diseases. Because of the bioeontainment issues related to arenavirus researeh, most military contributions have originated from the U.S. Army Medieal Researeh Institute of Infeetious Diseases (USAMRIID) in Fort Detrick, Maryland. Work performed at USAMRIID was responsible for mueh of our present understanding of arenavirus infections. In fact, the original deseriptions of two members of the Taearibe complex, Oliveros virus and Guanarito virus (the agent of Venzeuelan hemorrhagie fever) are attributable to work done at USAMjyjQ 131. 132 j^gy contributions were made in animal model development, pathophysiology and pathogenesis, human and rodent reservoir epidemiology, and vaeeine and therapeutie agent development. Names assoeiated with USAMRIID researeh are among the most prominent in the field of arenavirus study, ineluding C.J. Peters, Gerald Eddy, Peter Jahrling, Karl Johnson, and others.
In 1972, then-LTC Gerald Eddy left the National Institute of Allergy and Infeetious Diseases Mid-Ameriean Research Unit, where he had been involved in early groundbreaking researeh with Karl Johnson on South American arenaviruses, to beeome the ehief of virology at USAMRIID. Early arenavirus research under Dr. Eddy focused on Maehupo virus. The most important contributions from this time were the establishment of guinea pig and primate models for further study using a variety of monkey species.""*' Pathology and pathogenesis studies in these models greatly advanced our understanding of the arenavirus hemorrhagic fevers.'^^'^^ Dr. Eddy's group was the first to demonstrate that immune serum protected primates from acute disease in Machupo vims infection, confirming early reporis of successful passive immunization in other arenavims infections.'^^ Their studies also described the late neurological disease that is now a well-known sequela of arenavirus hemorrhagic fever treated with immune serum.'^^•'''°I n the early days of USAMRIID, arenavirus work was limited to the South American hemorrhagic fevers, because the Centers for Disease Control and Prevention (CDC) had laid claim to all research with Lassa virus (P. Jahrling, personal communication). This arrangement came to an abrupt end when a laboratory accident involving a tube of serum from infected Mastomys rodents exposed two CDC laboratory workers to a potentially fatal dose of Lassa virus. The two patients were brought to USAMRIID's clinical biocontainment facility, affectionately called "The Slammer." Their presence and the CDC's request for assistance launched USAMRIID's work on Lassa fever. Taking direction mostly from Peter Jahriing and C. J. Peters, Lassa fever research at USAMRIID made tremendous strides in passive immunization studies, drug discovery, and pathogenesis models.
Perhaps USAMRIID's most profound contribution was in therapeutic interventions for Lassa fever. Research at USAMRIID demonstrated that ribavirin could successfully treat Lassa virus infection in primate models.''""''"' Based on this research, the CDC and the Sierra Leone Ministry of Health conducted a series of human trials that definitively established ribavirin as the treatment of choice in severe Lassa fever.'''* Further work at USAMRIID looked at passive immune therapy. Animal model studies (many done at USAMRIID) and clinical experience indicated limited efficacy of immune semm in treating Lassa fever, possibly because of the late development and low titer of neutralizing antibodies after infection.'2°''*^'''Ĥ owever, animal studies conducted by Peter Jahriing and C.J. Peter's group did demonstrate efficacy of passive immune therapy (alone or in combination with ribavirin] if the immune semm was strain-specific and of high titer.''*^ Using a technique developed at USAMRIID, semm plasmapheresed from Lassa fever patients in Liberia was selected for high therapeutic efficacy.''"' Unforiunately, the immunoglobulin in those specimens was destroyed during processing at a biotechnology company, and efficacy in humans was never tested (P. Jahriing, personal communication).
The therapeutics research was far from USAMRIID's only output regarding Lassa fever and arenavims infections in general. Throughout this period, USAMRIID investigators produced instmmental studies on the pathogenesis and immunology of Lassa vims, in a variety of rodent and primate models. ' ' ' 2.145.146 Many of these examples are still the prototypical models for the study of Lassa vims today. Significant contributions were made in developing diagnostic serological tests and studying the aerosol stability and infectivity of Lassa vims.'''^'^^ Studies of Lassa fever patients in Liberia yielded discoveries about serological and biological diversity among Lassa vims isolates, timing of viremia, and humoral immune responses in human disease.'''^'^° Finally, model development of lymphocytic choriomeningitis vims infection in rodents and primates provided valuable tools for studies of Old World arenavims infections. For New Wodd arenavims studies, a lethal guinea pig model of Pichinde vims (a member of the Tacaribe complex) infection was developed at USAMRIID, allowing lethal arenavims animal model research to be conducted with minimal biocontainment.'"^''S'.'sŴ hile Lassa vims research progressed, USAMRIID continued to make strides in the field of the South American hemorrhagic fevers that were equally impressive. Guinea pig and primate model research continued, demonstrating pronounced strainspecific vimlence, the tendency for New World arenavimses to cause neurological disease, high infectivity by the aerosol route, greater imporiance of humoral immune responses (especially antibody-dependent cell-mediated cytotoxicity) for recovery compared with Lassa vims infection, and independence from immune responses of the physiological and organ system derangements caused by lethal infection.'''^'^^'^Ŝ ignificant progress was also made in therapeutic research for the South American hemorrhagic fevers. A double-blind trial performed in Argentina in 1979 definitively proved that immune semm treatment was effective against Argentine hemorrhagic fever, but the mechanisms of its efficacy and of the relatively frequent late neurological syndrome that followed remained a mystery.'^^ USAMRIID studies of guinea pig infections found that protection was based on antibody-dependent clearance of infected cells, rather than neutralization of vims. '^^'™ The neurological disease following immunotherapy was studied extensively in primate models. Animals with late neurological disease were found to have evidence of vims in brain tissue, a feature not found in the course of untreated infections. Although late neurological disease was seen more often with later initiation of treatment, it sometimes manifested in animals treated early and with higher doses of antisemm. Therefore, the mechanism of this syndrome was never completely elucidated.'^""'^^'^^ In addition to immune semm, guinea pig and primate studies of Junin infection showed beneficial responses to ribavirin, although late neurological manifestations were seen among some survlvors.'^^'^''^^ These studies paved the way for clinical trials of ribavirin in Argentine hemorrhagic fever, and this therapy is now considered a useful, if secondary, treatment.
Perhaps the most remarkable story in USAMRIID's arenavims research history is the development of the effective Candid 1 vaccine for Argentine hemorrhagic fever. In the middle 1970s, a prominent Argentine scientist. Dr. Julio Barrera Oro of the Instituto Malbran, Buenos Aires, came to USAMRIID through a collaborative effort with the Pan American Health Organization. He was advised through frequent contacts and visits to USAMRIID by Dr. Julio Maiztegui of the Laboratorio Nacional de Fiebre Hemorrhagica, Pergamino, Argentina. Both of these men worked closely with USAMRIID scientists Drs. Gerald Eddy and George French. Dr. Barrera Oro started with the XJ clone 3 isolate, a partially attenuated, mouse brain-passaged strain of Junin vims originally obtained from Dr. Jordi Casals at Yale University. It was adapted to diploid fetal rhesus lung cell culture at USAMRIID for use as a possible candidate vaccine by repeated cloning through limiting virus dilution and plaque selection. All subsequent passages, in-eluding primary and secondary seed preparation and vaccine production, were conducted in rigorously certified diploid cell cultures (G. Eddy, personal communication). This new virus proved to be genetically stable and was called "Candidate #1." It had no detectable peripheral virulence or neurovirulence in cell culture or rodent models. Dr. Barrera Oro truncated the name to "Candid 1," and study progressed toward human trials. Safety and immunogenicity studies were successful in primates, and Candid 1 proved to be 100% protective in a rhesus model of Junin infection, even at a very low dose of vaccine, when administered intramuscularly.'^'""' Candid 1 vaccine was produced at the Salk Institute facility in Swiftwater, Pennsylvania, and, after Phase I and II studies at USAMRIID and in Argentina, a large, placebo-controlled, randomized, blinded trial was conducted in Argentina."'* In 1988, USAMRIID researchers collaborated with Dr. Maiztegui at the Argentine National Institute for Hemorrhagic Fever Viruses, the Johns Hopkins University School of Public Health, and the Salk Institute to enroll 6,500 participants In a highly disease-endemic region in Argentina. Of the 23 participants who developed Argentine hemorrhagic fever during the next two harvest; seasons, 22 had received the placebo vaccine, yielding a vaccine efficacy of 95%. Rodent and nonhuman primate studies have since shown probable efficacy against Machupo virus infection as well. Since the Argentine trial, more than 175,000 doses of Candid 1 have been administered in Argentina, dramatically reducing the incidence of Argentine hemorrhagic fever. Unfortunately, lack of financial incentives and lack of production facilities in Argentina have made future prospects for Candid 1 tenuous.'^F iloviruses Although never having caused a symptomatic infection in an American, the filoviruses have become widely recognized names in this country, carrying with them a menacing stigma shared by few, if any, other diseases. The two members of the family Filoviridae, Marburg virus and Ebola virus, are prototypes of emerging infectious diseases. Both have been discovered in the past 40 years, with human outbreaks arising at irregular intervals, from human settlements in the deepest regions of subSaharan rain forests, and with increasing frequency in the past 10 years. The mysterious reservoir of these viruses, the unpredictable nature of outbreaks, the high mortality rates associated with infection, the gruesome descriptions of deaths from these viruses in the popular press, the unveiling of Soviet filovirus biological warfare programs, and the appearance of Ebola virus on American soil in 1989 have fueled an increased research effort over the past 15 years. Many of the most significant advances in filovirus research have come from U.S. military scientists.
As the name implies (filo is thread in Latin), the Filoviridae are uniquely structured viruses, having a rope-like, often filamentous appearance under electron microscopy. The virions consist of a helical nucleocapsid of closely associaited RNA and protein, with a tight-fitting envelope derived from the host cell and studded with viral proteins. Genomes are composed of a single segment of negative-sense RNA of approximately 19 kilobases, with a number of unique features.'^^ Recent taxonomic convention has clarified the relationship between the filoviruses. Because of a lack of serological cross-reactivity and the existence of differences in structure and genomic sequence, Ebola virus and Marburg virus have been classified as separate genera. Although Marburg virus has only one species, Ebola virus has four, i.e., Zaire, Sudan, Reston, and Cote d'lvoire.'^® In addition to genetic heterogeneity, the filoviruses are differentiated by epidemiological and clinical (specifically, mortality rates) features.'^^ Because all filoviruses cause hemorrhagic fevers with high mortality rates and are transmissible by the airborne route, they are classified as Biosafety Level 4 agents.
U.S. Military Significance
Filoviruses continue to be a focus for military biomedical research for two reasons, namely, the threat to troops deployed to disease-endemic areas and the threat of use as biological weapons. Filoviruses are stable in aerosol and are highly infectious by this route, making them attractive candidates for weaponization.'^^ Research for biodefense against filoviruses was spurred in the early 1990s by reports that the Soviet Union had active programs researching biowarfare applications of filoviruses and had potentially produced weapons with Marburg virus (P. Jahrling, personal communication).
The threat to deploying troops is centered in equatorial Africa. Marburg virus was discovered in 1967, when monkeys shipped from Uganda caused infection among laboratory workers in Germany and Yugoslavia. Since then, western/central Africa has remained the epicenter of human and nonhuman primate outbreaks of both Marburg virus and Ebola virus.™'^^'^^'™ A disturbing new development in the history of filoviruses occurred in 1989, when a new strain of Ebola virus was discovered in laboratory monkeys in Reston, Virginia.'^' These animals, as well several other shipments of monkeys later found to be infected with the newly discovered Ebola-Reston strain, were traced to a single distributor in the Philippines.'^^ The origins and location of Ebola vims in the Philippines remain a mystery.
Filovirus infections among deployed troops are of concern for several reasons. First, without working knowledge of a reservoir and route of acquisition in index cases, it is difficult to implement protective measures. Second, the mortality rates of these hemorrhagic fevers are potentially catastrophic for a deployed force. Mortality rates for Marburg hemorrhagic fever are generally quoted at 25%, although the recent outbreak in the Democratic Republic of the Congo had a reported mortality rate of more than 80%. '^°'^^ Disease from Ebola virus infection is fatal in 50 to 90% of cases, with disease from Ebola-Zaire occupying the high end of this spectrum. Only one case of Ebola-Cote d'lvoire infection, which was not fatal, has been documented. Ebola-Reston, although highly pathogenic in monkeys, has yet to cause disease among humans, although four people have had serological evidence of infection.'^^ However, the facts that Ebola-Reston appears to be easily transmitted through an airborne route, has a close relationship to Ebola-Zaire, and apparently exists outside Africa make it a concerning potential threat.
U.S. Military Contributions
Dr. Eugene Johnson was the impetus behind the earliest significant filovirus research in the U.S. military. A legendary eccentric. Gene Johnson was a civilian scientist at USAMRIID in the late 1970s and 1980s. He was well known in the field of filovirus research, evoking tremendous respect for his laboratory research and field epidemiology and at the same time causing profound frustration because he rarely published any of his work. In 1982, Karl Johnson moved from the Special Pathogens Division of CDC to become chief scientist at USAMRIID. He brought with him samples of Ebola-Zaire and gave them to Gene Johnson (P. Jahriing, personal communication). Using this seed. Gene Johnson, veterinary pathologist Nancy Jaax, and a group of researchers at USAMRIID produced some of the earliest and most important primate pathogenesis studies. Among the most important discoveries were the demonstration of aerosol transmission of filoviruses and the extensive pathological description of disease in primates."''"
In the middle/late 1980s, Gene Johnson's work focused on field epidemiology in an attempt to find the natural reservoir and transmission source for filoviruses, particularly Marburg virus. With the assistance of C.J. Peters and others, Dr. Johnson led USAMRIID researchers across the heart of Africa, trapping and testing thousands of insects, rodents, birds, and primates (P. Jahriing, personal communication). Particular efforts centered on Kitum cave, a common exposure site among some sporadic Marburg virus cases located near the border of Kenya and Uganda. These expeditions did not find a natural reservoir for filoviruses, adding to the mystery surrounding these viruses. They did provide valuable practice in field biocontainment procedures, and Richard Preston's recounting of Gene Johnson's team entering Kitum cave adorned with military gas masks and flower-patterned pillowcases makes for classic reading.''''
Military filovirus research was launched in earnest by a convergence of two phenomena at the start of the 1990s (P. Jahriing, personal communication). Intelligence reports of Soviet fllovlms biowarfare research, fueled by the testimony of defected scientist Ken Alibek, caused the sudden recognition of a significant military and national security threat. As this came to light, USAMRIID dove into filovirus research when electron-microscopist Tom Geisbert stared at the image of an obvious filovirus isolated from a fatal epizootic that was ravaging in a primate housing facility in Reston, Virginia.
Made famous in Richard Preston's book,'^"* the Reston outbreak was monumental for several reasons. Under the direction of Gene Johnson, C.J. Peters, and Peter Jahriing, USAMRIID researchers discovered that this was a new species of Ebola virus, which they named Ebola-Reston. The new virus was highly pathogenic in monkeys but apparently not in humans. The researchers dispelled the idea that filoviruses were found only in Africa, because the monkeys had been imported from the Philippines.'3°'^^ The investigators documented a high likelihood of aerosol transmission outside a controlled laboratory setting, because the virus appeared to pass between rooms to infect susceptible monkeys.'^^ Specimens from animals that died or were killed to eradicate the outbreak yielded fertile ground for research in new Ebola virus detection and identification techniques and the virological and pathological events associated with infection.'^'-'^e-isi
The Reston experience spurred a boom of Ebola virus research at USAMRIID. Important progress was made in understanding the transmission, pathophysiology, and immunology in primate models of infection.'^^'^'"'^^ USAMRIID developed enzyme immunoassays for improved and timely diagnosis of Ebola vims infections, and USAMRIID researchers remained involved in fleld studies in Africa, attempting to isolate vectors or reservoirs.'^''"'^Û SAMRIID has continued to produce some of the most important advances in filovirus research in the past decade, with the goal of finding preventive or therapeutic interventions for fllovirus infections. Mouse and guinea pig models developed by USAMRIID researchers have been invaluable tools in vaccine and therapeutic research.'^^"'3' Although humoral immunity is thought to play a secondary role in protection and recovery, studies of passive immune therapy at USAMRIID have shown some beneflcial effect that may be amplified if selected monoclonal antibodies are used.'^''^°'92-i94 -p^e first vaccine to protect primates from Marburg virus challenge, a Venezuelan equine encephalitis replicon vaccine, was developed at USAMRIID.' 35 Finally, USAMRIID has been intimately involved in the development of DNA-and adenovirus-vectored vaccines for Ebola virus, the combination of which has provided the first protection against Ebola virus infection in primates and will start human testing within the next several years.'^^'^^'^B ecause of mission and biocontainment requirements, military research with filoviruses has been confined to USAMRIID. From the laboratory and field research of Gene Johnson to the Reston outbreak to vaccine development, USAMRIID has been at the forefront of discovery in the study of Marburg and Ebola viruses over the past 20 years. Efforts continue across a wide spectrum of filovirus research and, as biodefense becomes a more urgent need in the 21st century, USAMRIID should continue to be an integral part of this filovirus research.
Hemorrhagic Fever with Renal Syndrome
The viruses that produce hemorrhagic fever with renal syndrome (HFRS) are in the family Bunyaviridae, genus Hantavirus. The Bunyaviridae share similar morphological features, with a spherical virion and a size between 80 and 120 nm.'^^ They contain a lipid envelope with two glycoproteins, which determine cell tropism and host pathogenicity and are sites for viral neutralization by antibody.'^^'^'''^^'^™The genetic organization of the Bunyaviridae consists of a single negative strand of RNA organized into three segments, i.e., large, medium, and small segments, which code for the virus nucleocapsid, glycoproteins, and polymerase proteins, respectively.^°'-^°^ Viral factors for the Bunyaviridae that are associated with human disease are medium segment-encoded polyproteins that contain a mucin-like domain and a furin cleavage site.^°^ Mucin-like domains and furin cleavage sites have been implicated in causing endothelial damage, cellular cytotoxicity, and interferon antagonism.^""* The Bunyaviridae may exert a direct effect on host gene regulation during infection, as evidenced by the hantaviruses' ability to suppress cellular interferon responses.^''T here are more than 20 genotypes of the genus Hantavirus, which are maintained in the environment by specific rodent species.^"^ Speciflc viruses in the genus Hantavirus are the Hantaan, Puumala, Seoul, Dobrava Belgrade, and Saarema viruses. All have specific geographic locations, as determined by the rodent host. Hantaan virus occurs in eastern Asia, Puumala virus in northem and eastern Europe, Seoul virus in Asia, and Dobrava Belgrade and Saarema viruses in central Euj.ope. 203, 206, 207 Human infection occurs by inhalation of infected rodent excreta. The genotype of Hhntavims determines the severity of clinical disease. Puumala virus, for example, produces nephropathia epidemica, which is a milder form of clinical illness, with a mortality rate of less than 1%.^"™ Seasonal occurrence is largely determined by the rodent species and human behavior leading to exposure. In Korea, two peaks occur, in the spring and autumn, with the latter being the largest peak of disease occurrence.^'" Persons at risk for infection are those with the greatest risk of exposure to rodent excreta, including farmers and soldiers. The age and gender distributions of cases reflect this population at risk, with cases occurring primarily among adult men,^"
The initial presentation of HFRS can be an abrupt onset of fever with severe headache, myalgia, and back and abdominal pain. Following an initial febrile period, there is an onset of hemorrhage, elevation of liver enzyme levels, and acute renal failure; renal failure is initially oliguric, followed by a polyuric phase.2'^ Unlike with the other viral hemorrhagic fever viruses, leukocytosis is a common laboratoiy finding. Renal biopsies revealed acute tubular necrosis, with interstitial cell infiltration and edema. Common causes of death are shock, respiratory failure, and pulmonary hemorrhage.^'^ In a retrospective analysis of HFRS among 26 U.S. soldiers, two patients had an initial presentation of severe shock and hemorrhage, with rapid onset of death.^'^ Eighteen patients presented with acute renal failure lasting approximately 21 days, and five patients presented with mild renal dysfunction. Several patients developed acute pulmonary edema requiring hemodialysis, and retroperitoneal hemorrhage was a major complication in this group. Six patients had a febrile illness with normal renal function, thrombocytopenia, abnormal urinalysis results, and transient elevation of liver enzyme levels,^'Û Today we have before us for discussion a disease entity which has created intense interest among both medical and lay personnel in the Far East Command. During the month of June 1951 there were admitted to the U.S. medical installations in Korea several patients with an acute febrile disease presenting a combination of symptoms and signs not previously encountered among United Nations personnel in Korea. The symptoms included malaise, weakness, chills, fever, headache (especially retrobulbar ache), blurred vision, nausea, and vomiting. These symptoms were associated with manifestations of hemorrhagic diathesis: petechial rash, marked injection of the conjunctiva, hematuria, and hematemesis (unpublished data).
COL McNinch went on to discuss the possible etiologies that were investigated. The first was drug sensitivity to chloroquine for the treatment of malaria. It soon became apparent that many soldiers who developed this condition had no history of chloroquine treatment. The next focus was on leptospirosis as a possible etiology. Leptospirosis was eliminated as a cause because of negative serological tests and pathology fmdings on autopsy that were not typical for leptospirosis. Between June 28 and July 23,1951,55 cases ofthis syndrome were observed, all from combat units of the 8th Army and the majority from a single division located northeast of Seoul. In July 1951, Surgeon General George Armstrong and MG Edgar Hume, Chief Surgeon of the Far East Command, were on an inspection visit in Korea and noted the high incidence of the leptospirosis-like illness. They arranged for COL Arthur Long, Far East Command consultant in preventive medicine, to investigate. He observed the clinical illness and called in COL Richard Mason, clinical pathologist from the Army Medical Service Graduate School, who confirmed that the disease entity was unlikely to be leptospirosis. Reports of the presence of a large number of field rodents in the areas from which cases were originating were confirmed. At that time, attention was directed toward a disease that the Japanese Army had encountered in Manchuria in 1939-1941. This disease was called by a variety of names, including Songo fever, Kokka disease, Korin fever, Nidoko disease, and epidemic hemorrhagic fever. Working with Japanese associates, a comparison of pathology slides for Japanese soldiers and U.S. soldiers confirmed that epidemic hemorrhagic fever, as described in the Japanese literature, was the same disease as that occurring among United Nation soldiers in Korea. A second peak to the epidemic occurred during 1951, with 28 cases, and confirmed Uie observations by Japanese military physicians. Case-fatality rates ranged from 13 to 18%. The Japanese described epidemic hemorrhagic fever as being attributable to a filterable vims maintained in the field rodent Apodemus agrarius. During this symposium, results of the investigation were presented by a number of Army scientists, including then-CPT Edward Buescher from the 406th Medical General Laboratory.
U.S. Military Contributions
The initial outbreak of hemorrhagic fever among United Na- RVF is an acute zoonotic disease that affects both ruminant animals and humans and occurs as an epizootic, with transmission to humans prtmarily from infected mosquitoes (Culex, Aedes, and Anopheles species) and secondartly from the handling of infected animal carcasses.^'"* RVF virus was isolated in 1930 in the Rift Valley of Kenya, in East Afrtca, and has been responsible for more than 30 large outbreaks of animal and human disease in East Afrtca since the 1930s. Weather pattern analysis demonstrated that RVF outbreaks followed pertods of abnormally high rainfall, which were predictive up to 5 months in advance of outbreaks.^^^ In 1977, RVF was responsible for a large outbreak of animal and human disease in Egypt, involving more than 18,000 clinical cases and 598 deaths.^^^ Subsequent outbreaks occurred in Maurttania in 1987, again in Egypt during 1993, and recentiy in Yemen and the Kingdom of Saudi Arabia in 2000. Saudi Arabia reported a total of 886 cases and a case fatality rate of 13.9%.^^^ The majortty of cases in Saudi Arabia occurred among adult men with significant rtsk factors for exposure to mosquito bites and infected animals. Age-specific mortality rates were greatest for the elderly, with an overall mortality rate in the population of 14%.^''° RVF virus is considered an emerging pathogen, causing considerable economic loss among domestic animals and human disease. Factors responsible for its emergence include the movement of infected livestock and mosquito vectors, global weather pattern changes. and economic development resulting in environmental conditions favortng mosquito breeding, such as pertods of heavy rainfall or the building of dams, with associated flooding of plains.^^T he major clinical charactertstics of RVF include hepatocellular failure, acute renal failure, and hemorrhagic manifestations.^'" Development of retinitis and meningoencephalitis is a late complication of the disease. Death has been observed in 33.9% of cases. Hepatorenal failure, shock, and severe anemia were all factors associated with death.^'"
Military scientists have contrtbuted to the understanding of the epidemiology, pathogenesis, and diagnosis of RVF. The full potential of RVF as a human pathogen and military threat was determined by military scientists from the Naval Medical Research Unit in Cairo, Egypt, during a large outbreak of RVF in Egypt in 1977.^^^ Four clinical syndromes were documented durtng that outbreak, i.e., a febrtle illness, encephalitis, ocular complications, and hemorrhagic disease. Other contrtbutions have been characterization of the virus and its vector and transmission cycle and the development of diagnostic assays.^^^•^''^"^'''' One of the most significant achievements by military scientists was in the analysis of weather patterns as a predictive model for RVF Chikungunya Chikungunya (CHIK) virus is classified in the family Togavirtdae, genus Alphavirus. The alphaviruses contain a nucleocapsid enclosed within a lipoprotein envelope containing a single strand of positive-polartty RNA. Two viral envelope glycoproteins, termed El and E2, exist and function as a heterodimer and the site for antibody neutralization.^"*^ CHIK is antigenically closely related to other alphaviruses, including O'nyong-nyong, Mayaro, and Semliki Forest viruses, and is serologically indistinct from O'nyong-nyong vims. CHIK is transmitted to humans by Aedes mosquitoes, prtmartly A. aegypU and Aedes africaHuman infection with CHIK is manifested by the sudden onset of fever, myalgia, headache, ocular pain, sore throat, nausea, and vomiting.^^° A maculopapular rash develops and is accompanied by enlarged tender lymph nodes. Severe joint arthralgias are common; they occur durtng the acute pertod and can last for several months into convalescence. Hemorrhagic manifestations can occur durtng acute CHIK infection and were observed during outbreaks in India and Southeast Asia. The hemorrhagic manifestations of CHIK were first observed during the early 1960s in Bangkok, Thailand, where approximately 10% of children admitted for dengue hemorrhagic fever were in fact suffertng from CHIK virus.^so-^s* Outbreaks of CHIK have been identified in Southeast Asia, India, Zambia, southeastern Zimbabwe, and Zaire.
U.S. Military
Significance CHIK was not a major problem among U.S. forces deployed in Vietnam and was not a significant factor in previous military operations. As an arbovirus with epidemic potential that can produce a sudden debilitating disease, its potential as a sertous military threat is considerable.
U,S, Military Contributions
Military scientists have contributed to our understanding of the epidemiology, transmission, and pathogenesis of CHIK vims infections. The significance of CHIK virus as a human pathogen was demonstrated during the early part of the dengue hemorrhagic fever outbreak in Southeast Asia, where its clinical manifestations and potential as a hemorrhagic fever virus were described. Military scientists also have contributed significantly in the development of both killed and live attenuated CHIK vaccines, demonstrating low reactogenicity and high immunogenicity in Phase I clinical studies.''""*
Summary of Key U,S, Military Contributions
The viral hemorrhagic fever viruses are a unique group of viruses that can produce severe, highly fatal human illnesses following the bites of mosquitoes or ticks, infected rodent or domestic animal exposure, or contact with other infected humans. They share common features in being able to directly induce cellular damage and to elicit an immune response among humans that can result in severe hemorrhage, coagulopathy, shock, and death. The characteristics of arthropod-bome or rodent-bome transmission, combined with illnesses that result in high morbidity and mortality rates, make the viral hemorrhagic fever vimses a unique threat to deployed soldiers around the world. The virai hemorrhagic fever vimses have historically been a major cause of disease for both U.S. and foreign soldiers, are currently a major cause of morbidity among U.S. soldiers, and will certainly be an ever-present disease threat for the U.S. military. The key military contributions are as follows: (1) leaders in the development of knowledge on the epidemiology and pathogenesis of dengue fever and dengue hemorrhagic fever, (2) development of numerous candidate dengue vaccines and a live attenuated dengue tetravalent vaccine currently in human clinical trials, (3) instmmental in gaining knowledge on the epidemiology and pathogenesis of YF, including the discovery of its transmission to humans from the bites of mosquitoes, (4) development of fundamental knowledge on the epidemiology and pathogenesis of the arenaviruses, (5) contribuUons in the characterization and testing of the Junin vaccine, (6) development of fundamental knowledge on the epidemiology and pathogenesis of filovimses and filovims vaccine development, (7) leaders in the development of knowledge on the epidemiology and pathogenesis of HFRS, (8) development of an effective antiviral dmg against HFRS, ribavirin, and the vaccine development program, and (9) development of fundamental knowledge on the epidemiology and pathogenesis of RVF and CHIK.
